Proceedings of the National Academy of Sciences, Volume 122, Issue 19, May 2025.
SignificanceThe development of small molecule KRAS inhibitors has proven to be a challenge. Recent clinical development of covalent KRAS G12C inhibitors demonstrates the potential of targeting KRAS oncogenic proteins directly. Compounds that target the …
Read More